Discovery and functional validation of a gut microbiota-metabolite-miRNA axis in diabetic encephalopathy

Key Points

• Diabetic encephalopathy is influenced by gut microbiota-derived metabolites and miRNAs, affecting neurological function.
• Key findings show that altering this microbiota-metabolite-miRNA axis significantly improves neurological outcomes in diabetic models.
• Research involved functional validation through experimental interventions that manipulated the microbiota and related metabolites.
• Highlights the need for further exploration into gut health as a target in diabetic complications and neurological health.